phone icon  Int'l : +1 (503) 505-6949
0
Shopping Cart is Empty..
$ 0

Medical Automation Technologies - Market Opportunities and Forecasts, 2014 -2020

 Pages:0
pubn Upcoming Date: Sep 2015
tab_nTables: 0
aut_nAuthor(s):
 p_n

The global medical automation technologies market provides various automated services in health monitoring, prescriptions, therapeutics etc. The global medical technologies market revenue stood at $300 billion in 2011 and it is expected to grow at a CAGR of 7% by 2016. The medical automation technologies market is expected to have a significant market share as highly automated and sophisticated services are available in the market. Venture capitalists are investing in the market to boost the development of medical automation, which is a key driver for the market. For example, Google started a healthcare company, Calio, and is now developing smart contact lens for monitoring diabetes.

However, companies have to go through stringent approval procedures to launch products or services which is a restraint for the growth of the market. U.S. FDA has been criticized in the past for over regulation and delay in product launches. Another challenge for companies in the market is to overcome the 2.3% excise tax burden on medical devices. Most of the companies are opposed to this tax and are demanding to repeal it.   

Some of the key companies profiled in this report are Acrobot Company Ltd., Awarepoint Corp., Clearcount Medical Solutions, Inc.,Ekahau Inc., Ge Healthcare, eScreen Inc. , iCad INC.,Intuitive Surgical, Inc., Philips Healthcare, Quiqmeds, Inc., t+ Medical Americas and U-Systems, Inc.

KEY BENEFITS

  • This report provides market intelligence with respect to health assessment & monitoring, automated imaging & image analysis, automated prescription formulation and dispensing, automated therapeutic (nonsurgical) procedures, medical robotics and computer-assisted surgical devices, automated laboratory testing and analysis, automated healthcare logistics, resource and personnel tracking and geographies so that companies can make precise investment decisions
  • Deep dive analysis of top factors affecting the market growth and their impact in the short and mid-term
  • Value chain analysis provides significance of the role of all stakeholders of the market
  • Porter’s five forces analysis offers insights into the potency of buyers and suppliers, competitive scenario of the market and the threat of new entrants and substitutes
  • SWOT analysis and strategic developments of key players are included in the report so that companies can understand the competitive landscape and make alterations in their plans to maintain their market share
  • Examine the challenges and opportunities in the medical automation technologies market so that companies can capitalize on the opportunities and increase revenue
  • Estimations are derived from the current market scenario and expected future trends for the period of 2013-2020 with 2012 as base figures
  • Geographic analysis offers in-depth implications of the trends in various regions and companies can make region specific strategies to gain competitive advantages

KEY MARKET SEGMENTSGLOBAL MARKET, BY AUTOMATED HEALTH ASSESSMENT AND MONITORING

  • Automated home monitoring and telemetry
  • Telehealth kiosks
  • Automated eye examination devices
  • Automated drug testing
  • Wearable monitors
  • Automated drug testing

GLOBAL MARKET, BY AUTOMATED IMAGING AND IMAGE ANALYSIS

  • Automated radiography and fluoroscopy
  • Automated whole-breast ultrasound
  • Computer-aided detection
  • Automated microscopy
  • Automated skin cancer detection
  • Endoscopic capsules
  • Automated microscopy

GLOBAL MARKET, BY AUTOMATED PRESCRIPTION FORMULATION AND DISPENSING

  • Packaging machines
  • Intravenous compounders
  • Dispensing machines

GLOBAL MARKET, BY AUTOMATED THERAPEUTIC (NONSURGICAL) PROCEDURES

  • Automated defibrillators
    • Portable Automated Defibrillators
    • Wearable Defibrillators
    • Implantable Defibrillators
  • Automated medication delivery systems
    • Implantable Drug Pumps
    • Wearable Drug Pumps

GLOBAL MARKET, BY MEDICAL ROBOTICS AND COMPUTER-ASSISTED SURGICAL DEVICES

  • Surgical planners and simulators
  • Surgical navigation systems
    • Imaging Technologies
    • Tracking Technologies
    • Display Technologies
  • Surgical robots
    • Robotically Assisted Micro-manipulation
    • Steady-hand Systems
    • Robotic “Wrists” and Other Dexterity Enhancements
    • Pre-programmed Robots
    • Constraint Robots
    • Voice Control
  • Intelligent operating rooms and related equipment
    • Data Routing
    • User Interface
    • Open System Architectures

GLOBAL MARKET, BY AUTOMATED LABORATORY TESTING AND ANALYSIS

  • Central Laboratory Systems
  • Point-of-care Testing Systems

GLOBAL MARKET, BY AUTOMATED HEALTHCARE LOGISTICS, RESOURCE AND PERSONNEL TRACKING

  • Automated hospital pickup and delivery
    • Pneumatic Tubes
    • Automated Guided Vehicles
  • Hospital asset/patient/staff tracking systems
    • Active RFID
    • Wi-Fi
    • Hybrid Systems
    • Sensor Tags
    • Real-time Location Systems

GLOBAL MARKET, BY GEOGRAPHY

  • North America
  • Europe
  • Asia-Pacific
  • RoW

KEY AUDIENCES

  • Medical automation technology providers
  • Healthcare sector service providers
  • Academic & research institutes
Let us know more about your research need and we will customize an offer exclusively for you!
*
*
*
*
*
*
*
security
*

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
icon_01
SINGLE
USER
icon_02
GROUP LICENSE
Icon_03
SITE
LICENSE
Icon_04
GLOBAL LICENSE
$3951
$4527
$5880
$8010
SUPPORT
Delivery Formats
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request
Get This Report
buy now
First time buyer ?
Check offers and discount
on this report
REQUEST QUOTE
Need More Information
phone_n +1 (503) 505-6949

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED PRODUCTS
get_n
SIMILAR MARKET REPORTS
  • ...
    Biomarkers are novel diagnostic tools that provide intelligence to physician about disease progression and treatment effects. Advancement in understanding of human genome promotes its application in diagnosis of disease on molecular basis. Biomarker technology is evidencing increased application in disease diagnosis, drug development and formulation, diagnosis for exposure of certain harmful chemical and prognostic treatments. The global market for diagnostic biomarker is expected to reach about $30.6 billion in 2020, growing at CAGR of 16% from 2013 to 2020.
    Dec 2013 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Synthetic biology is a novel field that finds its origin at the intersection of biology and engineering. It involves designing and construction of biological systems or devices that can be applied in varied domains to get specified results. Its a multidisciplinary effort made by scientists to understand the functioning of biological organisms, cells & genes and implementation of artificial genetic processes to give specific characteristics to an organism. It can even be used to develop a completely new biological system. Global synthetic biology market was valued at $3.0 billion in 2013 and it is estimated to reach $38.7 billion by 2020, growing at a CAGR of 44.2% during the forecast period.
    May 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Neuroprosthetics, also referred to as neural implants/brain implants, have gained significant momentum during past few years owing to the immense potential to substitute and/or ameliorate any damaged sensory, motor or cognitive functions. Such Neuroprosthetics are the key to restore and/or augment the ‘quality-of-life’ of the affected patient populace.
    Nov 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining prominence in the prostate cancer market. The global CRPC market is poised to expand at a significant pace, owing to high unmet clinical need, limited survival benefits, growing prevalence rates and fast emerging treatment modifications.
    Jul 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    Parenteral preparations are sterile, solid dosage form or pyrogen-free liquids, which contain one or more number of active ingredients boxed in single or multi dose containers. They are meant to be administered either by infusion, transplantation or injection in the body. Parenteral formulations are classified into small and large based on their volume. Small volume parenteral formulations are 100ml or more and can be given as single or multi dose, whereas large volume parenteral preparations are more than 100ml, intended for single use.
    Sep 2015 | View Details >>
  • ...
    Proton therapy is the most precise and advanced form of radiation therapy and is mainly used in the treatment of cancer. It offers significant benefits over conventional radiation therapy in terms of efficacy and limited side effects.
    Sep 2015 | View Details >>
  • ...
    A DNA vaccine is a small, circular DNA plasmid that encode one or more protein antigens under the control of a promoter to produce immune response against disease. DNA vaccines are basically the third generation vaccines that are specifically designed to overcome the unsought properties of conventional vaccines. The increasing vulnerability of population to infectious diseases and increasing number of antibiotics resistant pathogens have created the need for effective and low-cost vaccination, which would provide long lasting immunity.
    Sep 2015 | View Details >>
  • ...
    Objective of early toxicity testing in the drug discovery is to evaluate the safety of potential drug candidates. Relevant animal models are used to accomplish the procedure and validated procedures. This technique is ultimately used to understand the risk for humans by translating the animal response towards the drug.
    Sep 2015 | View Details >>